Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MODAFINIL vs MOMELOTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MODAFINIL vs MOMELOTINIB: Safety Overview

Metric MODAFINIL MOMELOTINIB
Total FAERS Reports 3,375 909
Deaths Reported 157 143
Death Rate 4.7% 15.7%
Hospitalizations 556 213
Average Patient Age 44.4 yrs 73.2 yrs
% Female Patients 62.0% 49.4%
FDA Approval Date Aug 16, 2017 Sep 15, 2023
Manufacturer Alembic Pharmaceuticals Limited GlaxoSmithKline LLC
Route ORAL ORAL
Marketing Status Prescription Prescription